Home › Funds › Citadel Advisors › DYN
Citadel Advisors position in DYN
DYNE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)11.60K sh
Reported value held$257.64K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 2.87M | $46.67M | New |
| Q4 2021 | 2.86M | $34.05M | Hold |
| Q1 2022 | 2.96M | $28.56M | Add |
| Q2 2022 | 2.93M | $20.10M | Reduce |
| Q3 2022 | 2.96M | $37.58M | Add |
| Q4 2022 | 2.99M | $34.60M | Add |
| Q1 2023 | 3.04M | $35.06M | Add |
| Q2 2023 | 2.71M | $30.53M | Reduce |
| Q3 2023 | 3.05M | $27.36M | Add |
| Q4 2023 | 3.10M | $41.18M | Add |
| Q1 2024 | 4.31M | $122.35M | Add |
| Q2 2024 | 4.33M | $152.81M | Hold |
| Q3 2024 | 2.97M | $106.80M | Reduce |
| Q4 2024 | 2.89M | $68.18M | Reduce |
| Q1 2025 | 3.07M | $32.13M | Add |
| Q1 2025 | 3.07M | $32.13M | Add |
| Q2 2025 | 960.37K | $9.14M | Reduce |
| Q2 2025 | 960.37K | $9.14M | Reduce |
| Q3 2025 | 3.46M | $43.74M | Add |
| Q4 2025 | 1.23M | $24.00M | Reduce |
| Q1 2026 | 240.54K | $4.36M | Reduce |
| Q2 2026 | 11.60K | $257.64K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DYN
- BlackRock Inc 12.40M sh · $275.50M · Q2 2026
- Fidelity Management & Research (FMR) 11.21M sh · $248.91M · Q2 2026
- Janus Henderson Group 13.65M sh · $247.43M · Q1 2026
- Vanguard Group 11.22M sh · $219.38M · Q4 2025
- Geode Capital Management 3.74M sh · $83.16M · Q2 2026
- JPMorgan Chase & Co 3.15M sh · $67.15M · Q2 2026
- Bank of America Corp 2.23M sh · $49.60M · Q2 2026
- Goldman Sachs Group 2.16M sh · $47.91M · Q2 2026
- Franklin Resources 2.03M sh · $45.10M · Q2 2026
- Marshall Wace 1.49M sh · $33.07M · Q2 2026
- Northern Trust Corp 1.28M sh · $28.39M · Q2 2026
- Charles Schwab Investment Management 1.20M sh · $26.70M · Q2 2026